#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12390	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2246	547.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1547	1547	C	693	C,T	682,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22370	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3677	605.7	0	.	n	.	0	T695C	SNP	695	695	T	1091	1091	C	704	C,T,A	686,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22370	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3677	605.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2367	2367	C	714	C,T	693,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22370	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3677	605.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2441	2441	A	680	A	670	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22370	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3677	605.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2993	2993	C	665	C	650	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22370	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3677	605.7	0	HET	.	.	.	A1638G	.	1638	1638	A	2034	2034	A	691	A,G	361,320	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1702	folP	855	855	100.0	folP.l15.c17.ctg.1	1599	105.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1036	1038	AGC	155;156;156	A;G;C	153;152;147	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	127.4	1	SNP	p	S91F	1	.	.	271	273	TTC	543	545	TTC	144;144;148	T;T;C	140;139;145	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	127.4	1	SNP	p	G95N	0	.	.	283	285	GGC	555	557	GGC	149;149;151	G;G;C	146;144;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	127.4	1	SNP	p	D95G	1	.	.	283	285	GGC	555	557	GGC	149;149;151	G;G;C	146;144;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1496	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1588	93.8	1	SNP	p	G45D	0	.	.	133	135	GGC	711	713	GGC	163;162;160	G;G;C	159;159;156	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	752	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	988	75.3	0	.	n	.	0	A197.	DEL	197	197	A	531	531	A	163	A	158	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3066	130.2	1	SNP	p	D86N	0	.	.	256	258	GAC	661	663	GAC	163;164;165	G;A;C	159;160;164	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3066	130.2	1	SNP	p	R87W	0	.	.	259	261	CGT	664	666	CGT	165;167;167	C;G,A;T,G	163;162,1;158,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3066	130.2	1	SNP	p	S87R	1	.	.	259	261	CGT	664	666	CGT	165;167;167	C;G,A;T,G	163;162,1;158,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3066	130.2	1	SNP	p	R87I	0	.	.	259	261	CGT	664	666	CGT	165;167;167	C;G,A;T,G	163;162,1;158,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3066	130.2	1	SNP	p	S88P	0	.	.	262	264	TCC	667	669	TCC	167;167;167	T;C;C,A	164;162;164,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3422	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2517	134.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1466	1468	GGC	168;166;167	G;G;C	163;164;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1288	1290	GCC	181;182;182	G;C;C,A	173;178;174,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1291	1293	ATG	182;180;179	A;T;G	176;172;172	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1303	1305	ACC	186;183;183	A;C;C	180;179;179	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1303	1305	ACC	186;183;183	A;C;C	180;179;179	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1804	1806	ACC	167;167;169	A;C;C	162;167;168	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1858	1860	GCG	139;138;139	G;C;G	139;137;138	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1858	1860	GCG	139;138;139	G;C;G	139;137;138	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1981	1983	GGT	121;119;116	G;G;T	117;117;114	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1990	1992	AGC	109;108;104	A;G;C	106;103;101	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2444	140.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2008	2010	CCG	82;85;85	C,G;C;G	73,2;75;68	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4830	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3243	148.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1680	1682	CCG	143;143;144	C;C;G,C	138;138;139,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2170	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1920	112.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	595	595	C	153	C,G	145,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2330	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1604	143.2	1	SNP	p	G120K	1	.	.	358	360	AAG	657	659	AAG	168;167;169	A,G;A;G,C	158,1;164;154,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2330	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1604	143.2	1	SNP	p	A121N	1	.	.	361	363	AAC	660	662	AAC	168;165;164	A,G;A,C;C	161,1;158,1;152	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2330	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1604	143.2	1	SNP	p	N121D	0	.	.	361	363	AAC	660	662	AAC	168;165;164	A,G;A,C;C	161,1;158,1;152	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8174	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4838	168.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1008	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1044	95.7	1	SNP	p	V57M	1	.	.	169	171	ATG	547	549	ATG	184;185;182	A;T;G	184;184;182	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
